Development from recurrent anti-N-methyl-D-aspartate receptor encephalitis with seizures as the first symptom to autoimmune-associated epilepsy: a case report
Abstract Background Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a novel autoimmune encephalitis (AE) first identified in 2007. It provides a new direction for clinicians when encountering unexplained symptoms such as seizures, psychotic behavioral abnormalities, speech disorders,...
Main Authors: | Ningxiang Qin, Jing Wang, Xi Peng, Liang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | Acta Epileptologica |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42494-023-00129-0 |
Similar Items
-
Anti-N-methyl-D-aspartate receptor encephalitis: a new autoimmune encephalitis
by: Xiang-jun Chen, et al.
Published: (2013-01-01) -
FLAMES overlaying anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review
by: Rimei Zhong, et al.
Published: (2024-04-01) -
The association between autoimmune encephalitis mediated by N-methyl-ᴅ-aspartate receptor autoantibodies and COVID-19: a systematic review
by: Ahmad Sawalha, et al.
Published: (2024-01-01) -
Late relapse of anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis: a case report
by: Hamidreza Amiri, et al.
Published: (2024-11-01) -
Higher incidence of acute symptomatic seizures in probable antibody-negative pediatric autoimmune encephalitis than in major antibody-positive autoimmune encephalitis
by: Naoki Yamada, et al.
Published: (2024-07-01)